Fabian Frontzek

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Venues

Leukemia

Blood

Blood advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia 38 (5) (2024)
Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia 38 (5) (2024)
Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia 38 (5) (2024)
Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia (2024)
Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial. Leukemia 38 (5) (2024)
Fabian Frontzek, Richard Greil, Ulrich Dührsen, Viola Poeschel, Sophie Bernard, Loïc Chartier, Nicolas Ketterer, Christian Récher, Olivier Fitoussi, Gerhard Held, René-Olivier Casasnovas, Corinne Haioun, Nicolas Mounier, Hervé Tilly, Judith Trotman, Steven Le Gouill, Imke E Karsten, Gerben Duns, Christian Steidl, David W Scott, Wolfram Klapper, Andreas Rosenwald, German Ott, Thierry Molina, Georg Lenz, Marita Ziepert, Bettina Altmann, Catherine Thieblemont, Norbert Schmitz
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration. Leukemia (2024)
Fabian Frontzek, Annette M Staiger, Ramona Wullenkord, Michael Grau, Myroslav Zapukhlyak, Katrin S Kurz, Heike Horn, Tabea Erdmann, Falko Fend, Julia Richter, Wolfram Klapper, Peter Lenz, Stephan Hailfinger, Anna Tasidou, Marcel Trautmann, Wolfgang Hartmann, Andreas Rosenwald, Leticia Quintanilla-Martinez, German Ott, Ioannis Anagnostopoulos, Georg Lenz
Molecular profiling of EBV associated diffuse large B-cell lymphoma. Leukemia (2023)
Fabian Frontzek, Annette M Staiger, Ramona Wullenkord, Michael Grau, Myroslav Zapukhlyak, Katrin S Kurz, Heike Horn, Tabea Erdmann, Falko Fend, Julia Richter, Wolfram Klapper, Peter Lenz, Stephan Hailfinger, Anna Tasidou, Marcel Trautmann, Wolfgang Hartmann, Andreas Rosenwald, Leticia Quintanilla-Martinez, German Ott, Ioannis Anagnostopoulos, Georg Lenz
Molecular profiling of EBV associated diffuse large B-cell lymphoma. Leukemia 37 (3) (2023)
Fabian Frontzek, Annette M Staiger, Ramona Wullenkord, Michael Grau, Myroslav Zapukhlyak, Katrin S Kurz, Heike Horn, Tabea Erdmann, Falko Fend, Julia Richter, Wolfram Klapper, Peter Lenz, Stephan Hailfinger, Anna Tasidou, Marcel Trautmann, Wolfgang Hartmann, Andreas Rosenwald, Leticia Quintanilla-Martinez, German Ott, Ioannis Anagnostopoulos, Georg Lenz
Molecular profiling of EBV associated diffuse large B-cell lymphoma. Leukemia 37 (3) (2023)
Fabian Frontzek, Annette M Staiger, Ramona Wullenkord, Michael Grau, Myroslav Zapukhlyak, Katrin S Kurz, Heike Horn, Tabea Erdmann, Falko Fend, Julia Richter, Wolfram Klapper, Peter Lenz, Stephan Hailfinger, Anna Tasidou, Marcel Trautmann, Wolfgang Hartmann, Andreas Rosenwald, Leticia Quintanilla-Martinez, German Ott, Ioannis Anagnostopoulos, Georg Lenz
Molecular profiling of EBV associated diffuse large B-cell lymphoma. Leukemia 37 (3) (2023)
Catherine Thieblemont, Bettina Altmann, Fabian Frontzek, Richard Greil, Loic Chartier, Nicolas Ketterer, Christian Récher, Viola Poeschel, Olivier Fitoussi, Gerhard Held, Olivier Casasnovas, Corinne Haioun, Judith Trotman, Bertram Glass, Nicolas Mounier, Herve Tilly, Andreas Rosenwald, German Ott, Georg Lenz, Thierry Jo Molina, Marita Ziepert, Norbert Schmitz
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/ DSHNHL analysis. Blood advances (2023)
Fabian Frontzek, Annette M Staiger, Ramona Wullenkord, Michael Grau, Myroslav Zapukhlyak, Katrin S Kurz, Heike Horn, Tabea Erdmann, Falko Fend, Julia Richter, Wolfram Klapper, Peter Lenz, Stephan Hailfinger, Anna Tasidou, Marcel Trautmann, Wolfgang Hartmann, Andreas Rosenwald, Leticia Quintanilla-Martinez, German Ott, Ioannis Anagnostopoulos, Georg Lenz
Molecular profiling of EBV associated diffuse large B-cell lymphoma. Leukemia 37 (3) (2023)
Wendan Xu, Philipp Berning, Tabea Erdmann, Michael Grau, Nardjas Bettazová, Myroslav Zapukhlyak, Fabian Frontzek, Corinna Kosnopfel, Peter Lenz, Michael Grondine, Brandon Willis, James T Lynch, Pavel Klener, Stephan Hailfinger, Simon T Barry, Georg Lenz
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma. Leukemia (2022)
Fabian Frontzek, Imke Karsten, Norbert Schmitz, Georg Lenz
Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma. Therapeutic advances in hematology 13 (2022)
Norbert Schmitz, Fabian Frontzek
CNS prophylaxis in DLBCL: time to say goodbye? Blood 139 (3) (2022)
Fabian Frontzek, Georg Lenz
Tackling ALK-positive LBCL. Blood 140 (16) (2022)
Fabian Frontzek, Annette M Staiger, Myroslav Zapukhlyak, Wendan Xu, Irina Bonzheim, Vanessa Borgmann, Philip Sander, Maria Joao Baptista, Jan-Niklas Heming, Philipp Berning, Ramona Wullenkord, Tabea Erdmann, Mathias Lutz, Pia Veratti, Sophia Ehrenfeld, Kirsty Wienand, Heike Horn, John R Goodlad, Matthew R Wilson, Ioannis Anagnostopoulos, Mario Lamping, Eva González-Barca, Fina Climent, Antonio Salar-Silvestre, Josep Castellví, Pau Abrisqueta, Javier Menarguez, Teresa Aldamiz, Julia Richter, Wolfram Klapper, Alexandar Tzankov, Stefan Dirnhofer, Andreas Rosenwald, José Luis Mate, Gustavo Tapia, Peter Lenz, Christoph Cornelius Miething, Wolfgang Hartmann, Björn Chapuy, Falko Fend, German Ott, Jose-Tomás Navarro, Michael Grau, Georg Lenz
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nature communications 12 (1) (2021)

Fabian Frontzek.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fabian Frontzek